J&J agrees to supply African Union with up to 400 million COVID shots

Johnson & Johnson has agreed to supply up to 400 million doses of its COVID-19 vaccine to the African Union (AU) from the third quarter of 2021, the drugmaker said on Monday, as the continent struggles to get shots into arms and tame infections.

J&J agrees to supply African Union with up to 400 million COVID shots

J&J unit Janssen Pharmaceutica NV has entered into a deal with the African Vaccine Acquisition Trust (AVAT) to deliver 220 million doses of its single-dose shot.

AVAT could order an additional 180 million doses through 2022.